Key Points
- COO Graham Reeve sold 662 shares on March 11 at an average price of $78.86 for $52,205.32, reducing his stake by 2.15% to 30,078 shares valued at about $2.37 million.
- Dividend raised to $0.46 quarterly (from $0.45) with an ex-dividend date of March 13 and a yield of 2.4%, though the dividend payout ratio is a high 126.76%.
- Recent results and outlook: Q4 revenue beat at $202.73 million (+12.3% YoY) with EPS $0.67 in line, the stock trades around $76.82 with a market cap of $1.16 billion and a consensus analyst rating of "Moderate Buy" (price target $104.50).
U.S. Physical Therapy, Inc. (NYSE:USPH - Get Free Report) COO Graham Reeve sold 662 shares of the business's stock in a transaction on Wednesday, March 11th. The stock was sold at an average price of $78.86, for a total value of $52,205.32. Following the sale, the chief operating officer directly owned 30,078 shares in the company, valued at $2,371,951.08. This trade represents a 2.15% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website.
U.S. Physical Therapy Trading Down 1.4%
Shares of NYSE USPH traded down $1.06 during mid-day trading on Friday, hitting $76.82. 92,630 shares of the company traded hands, compared to its average volume of 217,387. The company has a quick ratio of 1.01, a current ratio of 1.01 and a debt-to-equity ratio of 0.32. U.S. Physical Therapy, Inc. has a 1 year low of $62.77 and a 1 year high of $93.50. The stock has a market capitalization of $1.16 billion, a price-to-earnings ratio of 54.28, a PEG ratio of 2.01 and a beta of 1.30. The business has a 50 day moving average of $83.83 and a two-hundred day moving average of $82.24.
U.S. Physical Therapy (NYSE:USPH - Get Free Report) last posted its quarterly earnings data on Thursday, February 26th. The company reported $0.67 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.67. U.S. Physical Therapy had a return on equity of 8.75% and a net margin of 5.07%.The firm had revenue of $202.73 million for the quarter, compared to the consensus estimate of $200.10 million. During the same quarter in the previous year, the company earned $0.51 EPS. The business's revenue for the quarter was up 12.3% compared to the same quarter last year. On average, sell-side analysts anticipate that U.S. Physical Therapy, Inc. will post 2.67 earnings per share for the current fiscal year.
U.S. Physical Therapy Increases Dividend
The company also recently declared a quarterly dividend, which will be paid on Friday, April 10th. Stockholders of record on Friday, March 13th will be issued a dividend of $0.46 per share. This is an increase from U.S. Physical Therapy's previous quarterly dividend of $0.45. This represents a $1.84 dividend on an annualized basis and a dividend yield of 2.4%. The ex-dividend date is Friday, March 13th. U.S. Physical Therapy's dividend payout ratio (DPR) is presently 126.76%.
Institutional Inflows and Outflows
A number of institutional investors and hedge funds have recently added to or reduced their stakes in USPH. Hantz Financial Services Inc. boosted its stake in shares of U.S. Physical Therapy by 56.4% during the 4th quarter. Hantz Financial Services Inc. now owns 366 shares of the company's stock valued at $29,000 after buying an additional 132 shares during the period. Advisory Services Network LLC acquired a new position in shares of U.S. Physical Therapy in the third quarter worth $39,000. EverSource Wealth Advisors LLC raised its holdings in shares of U.S. Physical Therapy by 68.8% during the third quarter. EverSource Wealth Advisors LLC now owns 471 shares of the company's stock worth $40,000 after acquiring an additional 192 shares in the last quarter. GAMMA Investing LLC raised its holdings in shares of U.S. Physical Therapy by 207.1% during the fourth quarter. GAMMA Investing LLC now owns 516 shares of the company's stock worth $40,000 after acquiring an additional 348 shares in the last quarter. Finally, Assetmark Inc. boosted its position in U.S. Physical Therapy by 35.7% during the second quarter. Assetmark Inc. now owns 570 shares of the company's stock valued at $45,000 after purchasing an additional 150 shares during the last quarter.
Wall Street Analysts Forecast Growth
A number of equities analysts recently commented on the stock. Barrington Research reaffirmed an "outperform" rating and issued a $103.00 price objective on shares of U.S. Physical Therapy in a research note on Friday, February 20th. Citigroup reissued a "market outperform" rating on shares of U.S. Physical Therapy in a research note on Monday, December 15th. JPMorgan Chase & Co. decreased their target price on U.S. Physical Therapy from $110.00 to $100.00 and set an "overweight" rating for the company in a research report on Monday, November 24th. Jefferies Financial Group upgraded U.S. Physical Therapy to a "strong-buy" rating in a report on Thursday. Finally, Weiss Ratings reissued a "hold (c)" rating on shares of U.S. Physical Therapy in a research report on Wednesday, January 21st. One analyst has rated the stock with a Strong Buy rating, four have assigned a Buy rating and two have issued a Hold rating to the stock. According to MarketBeat, U.S. Physical Therapy has a consensus rating of "Moderate Buy" and a consensus price target of $104.50.
Get Our Latest Report on U.S. Physical Therapy
U.S. Physical Therapy Company Profile
(
Get Free Report)
U.S. Physical Therapy, Inc (NYSE: USPH) is a leading owner and operator of outpatient physical therapy clinics across the United States. The company delivers rehabilitative care to patients recovering from orthopedic injuries, neurological disorders and chronic conditions. Its core services include one-on-one physical therapy sessions, aquatic therapy, occupational therapy, massage therapy and sports medicine programs designed to restore mobility and enhance quality of life.
In addition to traditional rehabilitation services, U.S.
Further Reading
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
